Highlights
NASDAQ: PPHM       Peregrine Pharma New
Last Price Today's Change   Day's Range   Trading Volume
0.55   0.00 (0.00%)  0.53 - 0.56  233,325

Overview

 
Avg Volume (4 weeks):946,163
4 Weeks Range:0.53 - 0.68
4 Weeks Price Volatility (%):
13.33%
52 Weeks Range:0.28 - 0.774
52 Weeks Price Volatility (%):
54.66%
Average Price Target: 2.30
Price Target Upside/Downside: +1.75

Headlines



No recent Headlines for this stock.


Business Background

Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company. The Company operates through two segments: Peregrine, which is engaged in the research and development of monoclonal antibodies for the treatment of cancer, and Avid, which is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. Bavituximab is its lead immunotherapy candidate. Bavituximab is a monoclonal antibody that targets and binds to phosphatidylserine (PS), a immunosuppressive molecule that is usually located inside the membrane of healthy cells, but then flips and becomes exposed on the outside of cells in the tumor microenvironment, causing the tumor to evade immune detection. The Company's subsidiary is Avid Bioservices, Inc. (Avid). Avid provides integrated current good manufacturing practices (cGMP) services from cell line development to commercial biomanufacturing.

  Be the first to like this.
 


 

3377  3203  749  1034 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GPACW 0.20-0.14 
 NTRSP 27.04-0.04 
 F 11.03+0.16 
 BAC 22.87-0.18 
 AMD 11.055-0.355 
 XLF 23.29-0.06 
 DCTH 0.030.00 
 TVIX 26.12-2.05 
 PBR 8.625-0.335 
 HUN 26.688-0.022 
Partners & Brokers